Bovine Mastitis Market, By Type (Clinical and Sub-Clinical), By Product (Antibiotics and Others), By Route of Administration (Intramammary and Systemic), By Therapy (Lactating Period and Dry Period (Antibiotics and Others)), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) – Global Forecast till 2029

The market for technology related to bovine mastitis was valued at US$ 1.3 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 5.3% to reach US$ 2.1 billion by 2029.

The medical condition known as bovine mastitis typically affects dairy animals. This condition manifests as inflammation of the mammary gland and udder tissue. It can also cause harm to the tissues in cattle that secrete milk, which is one of the main reasons it's seen to be a significant condition. The Cornell University College of Veterinary Medicine reports that the incidence of bovine mastitis worldwide ranges from 0 to 200 cases per 100 cows. Furthermore, according to the University of Glasgow, the annual healthcare burden caused by bovine mastitis is estimated to be between $19.7 billion and $30 billion. Furthermore, a major factor driving the overall market growth is the rise in mastitis infections during the dry season and the expanding benefits of various non-antibiotic intramammary products, like teat sealants, in preventing new intramammary infections during this time.